SCHEMBL16769879

SCHEMBL16769879

CCCCc1ccc(/C=C2\CN(S(=O)(=O)c3ccccc3)C/C(=C\c3ccc(CCCC)cc3)C2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ TSHR P16473 1/20 0.47
▸ DRD3 P35462 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ CARM1 Q86X55 2/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ MDM2 Q00987 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ ACHE P22303 4/20 0.42
▸ BCHE P06276 2/20 0.42
▸ CNR2 P34972 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ MCOLN3 Q8TDD5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16755544 1.00 KMT2A (0.47) KMT2AMEN1TSHRDRD3ALDH1A1
SCHEMBL16755542 1.00 KMT2A (0.47) KMT2AMEN1TSHRDRD3ALDH1A1
SCHEMBL16755583 0.93 KMT2A (0.49) KMT2AMEN1TSHRDRD3ALDH1A1
SCHEMBL16755581 0.93 KMT2A (0.49) KMT2AMEN1TSHRDRD3ALDH1A1
SCHEMBL16769875 0.93 KMT2A (0.49) KMT2AMEN1TSHRDRD3ALDH1A1
SCHEMBL19840313 0.89 CD4 (0.47) KMT2AMEN1DRD3ALDH1A1LMNA
SCHEMBL15562369 0.89 CD4 (0.47) KMT2AMEN1DRD3ALDH1A1LMNA
SCHEMBL15562368 0.89 CD4 (0.47) KMT2AMEN1DRD3ALDH1A1LMNA
SCHEMBL16755580 0.88 HSD11B1 (0.48) KMT2AMEN1TSHRALDH1A1LMNA
SCHEMBL16769886 0.88 HSD11B1 (0.48) KMT2AMEN1TSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 — — US disclosed
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 — — US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 — — US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof COX15, HCCS, HMOX2 KMT2A 2801/4885MEN1 1508/4885TSHR 4777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback